Elder Pharmaceuticals ltd. - ONE STOCK TO WATCH

Elder Pharmaceuticals Ltd is one of the fastest growing pharmaceutical companies in India. The company's principal activities include the manufacturing and marketing of prescription pharmaceutical brands, surgical and medical devices. They are engaged in the manufacture of a wide range of pharmaceutical product through research and development and also in the manufacturing and marketing of diverse products through licensing agreements with international pharmaceutical companies. They are also engaged in the manufacturing of active pharmaceutical ingredients. Elder Pharmaceuticals Ltd was incorporated on April 2, 1983 in Maharashtra. The company started their commercial activities in the year 1988. In the year 1989, they commissioned their first factory in Navi Mumbai. The company was converted into a public limited company in August 1998. Over the years, the company launched the medicines either through their own research or through alliances with global companies. The company entered into strategic alliances with a number of international pharmaceutical entities for marketing their products in India and overseas international acquisitions have strengthened and enabled the company to become a true-global pharmaceutical company.

 They made the tie up with Haw Par, Singapore during the year 1994 and Fujisawa during the year 1998. During the year 2000-01, the company entered into joint venture agreement with Stiefel Laboratories Inc. Also they made a tie up with Paul Hartmann of Germany for marketing their incotinence and wound healing in India. During the year 2002-03, the company made a tie up with an American company namely, Blistex Inc, for license manufacturing and distribution of their Lip Care products. The company entered into technical/ marketing collaborations with Covex and Ferrer of Spain for their products for Cognitive disorders, Cerebral strokes and Head injuries, Tanabe Seiyaku and Fujisawa of Japan for their products for Hypertension and Heart Failure and TRB Chemeica of Switzerland for their product for Osteoarthritis. During the same year, the company entered into new joint venture agreement with the Universal Group of Companies, Nepal for setting up a pharmaceutical formulations plant in Nepal. In March 2003, they started their operation in their Bulk Drug plant at Patalganga. During the year 2004-05, the company acquired an international brand 'Tobraneg' from Ely Lilly and company of USA at a price of Rs 172.50 lakh. During the year 2005-06, they commissioned one of their new manufacturing units at Sela Qui in Uttarakhand, which is equipped to manufacture tablets and capsules. The company introduced 'Somazina', a neuroprotector during the year. During the year 2006-07, the company introduced Eldervit ZC, Redirinse, Nedge, Bonviva and Deviron in the market. Also, they entered with the alliances with Roche of Switzerland for their product 'Bonivini', Daiwa of Japan for their product 'Biobran' & 'NKCP', Enzymotec of Isreal for their product 'Cardiabeat' and Almirall of Spain for the product 'Cinitapride'. The company commenced commercial production of manufacturing of topical formulation in their plant at Paonta Sahib in Himachal Pradesh during the year. They commissioned a betalactum plant in Nepal through a joint venture with Universal Pharmaceuticals. The company also entered into joint venture with Vincom Pharmaceuticals in Ghana for Oral Liquid dosages. In January 2007, the company established a wholly owned subsidiary, called Elder International FZCO in the Jebel Ali Free Trade Zone, Dubai. During the year 2007-08, the company got associated with Cymbiotics of California, USA for marketing six of their patented products for Diabetes, Chrobnic pain, Skin Care, etc. and Gnosis of Italy for marketing of 'Sampure'. They formed a wholly owned subsidiary in Cyprus by the name Somerta Holdings Co Ltd with a capital of Euro 5000. The company through their wholly owned subsidiary, Elder International FZCO acquired a 100% stake in Neutra health PLC, an AIM London Stock Exchange listed company and also established a wholly owned subsidiary in Bulgaria by the name 'Elder Biomeda EDA' with the object of acquiring 100% stake in three Biomeda Group companies for the total investment of Euro 3.12 million. The company was awarded Amity Corporate Excellence Award for the year 2008 and Frost & Sullivan Market Leadership Award for 'Shelcal' for the year 2008. They have been named in the Forbes list of 'Asia's 200 Best under a billion' over a period of three years. In November 2008, the company entered into a deal with Japan's Daiwa Pharmaceuticals Co Ltd for manufacturing and marketing of some of their products in India. 

Also,On 7^th February 2012 they acquired 100% stake in three Bulgarian pharma companies through their wholly owned Bulgarian subsidiary Elder Biomeda EAD.

I am hopeful that some of these projects will enter the late stage development, indicating even better days for the Company. Hence one can buy Elder Pharmaceuticals Ltd at CMP 179 for long term.It is listed in both the exchanges,scrip code 532322.

LINK TO COMPANY WEBSITE CLICK HERE              

DISCLOSURE: IT IS SAFE TO ASSUME THAT I HAVE VESTED INTEREST IN Elder Pharmaceuticals Ltd.

Himalya International Ltd - VALUE BUYING STOCK ?

Himalaya International Limited is an India-based frozen food company, engaged in processing mushrooms, baby potatoes and buffalo cheese. The Company is engaged in manufacturing of mushroom, vegetables, cheese, yogurt, appetizers, snacks and sweets and daily one tablet. The Company offers three varieties of Mushrooms: White (Agaricus), Crimini (Italian Brown) and Portobello. It is also engaged in processing of vegetables and baby potatoes. Himalya International s work ethics, product quality, innovation, diversification and customer care are only a few attributes that set the company apart from others and make it an ideal business partner. Not only does Himalya excel in offering a wide assortment of products, but also time and again the company has catered to the needs of its customers through innovative as well as custom fit produce. Its ideal location, which is the foothills of the mighty Himalayas with freshest of Air, amidst pristine glacier blue underground water sources and the richest of soils, make this aspect quite simple really; here anything flourishes. Nature itself lends a hand to the already unpolluted, green acres. Since 1979 the company, which started as a small unit, has never looked back. At Himalya, strategic planning based on predictive customers needs has always set the momentum for constant diversification within the Specialty Foods.The Company launched its All Natural chilled and frozen products under its brand Himalya Fresh. Himalya International Inc. is the Company subsidiary in United States of America, engaged in exploring its cheese business in Company. The company, which started as an export unit has recently decided to enter domestic market to capture the burgeoning Indian market. For Overseas customers, Himalya provides 24x7 support from its dedicated Back Office.

One of the India's foremost diversified Agribusiness Company Himalya International was formed in 1979. Having the advantage of India's first frozen food company Himalya always tries to satisfy not only the ravenousness of food but much more than that.  Pioneer in the multiple instances, Himalya has incessantly rejuvenated itself, only to become more preferred.Nestled in the lap of Himalya we have the gratification of purest of all the natural resources. Squad of 500 people all having expertise in agriculture management, plant pathology, storage, farm mechanization and all with the view of making the food taste you cherish. On its 25 acre complex Himalaya has four complementing production units.

If everything is correct and company can materialize its future plans ,stock may turn as a value buying from current level of just Rs.13 in next few years.Stock listed only in BSE with scrip code 526899.

Disc : I have vested interest in "Himalya International Ltd".

Shree Ganesh Jewellery House (I) Ltd - The best bet in Jems & Jewellery sectors .

Shree Ganesh Jewellery House Ltd is the largest manufacturer and exporter of hallmarked and handcrafted gold jewellery in India. The company is engaged in the manufacturing and exporting of handcrafted gold and studded jewellery. Their products are primarily exported to countries such as the UAE, Singapore, Middle East, Europe, Hongkong and Srilanka.

Design SGJHL Wins 2nd Prize in Cocktail Category at JAS 2013, Jaipur. On behalf of the company, the award was received by Mr. Rahul Singh-Head-Marketing and Corporate Communications along with designer-Subal Guin. The ring is made of 18k Gold and set with Blue tourmaline, Diamonds & Ruby. 
Leading celebrity couturier and fashion designer Sabyasachi Mukherjee was an empanelled designer with the company from 2008-2012 and had launched the GAJA SABYASACHI COLLECTION which was targeted at the high end clientele.. The collection is being designed by Sabyasachi Mukherjee and is adorned by leading Bollywood / Tollywood actress like Aishwarya Rai Bachchan in Guzaarish, Rani Mukherjeeand, Vidya Balan. Other bollywood actors like Juhi Chawla, Kiron Kher and Bengali actors like Rituparna Sengupta, Swastika, Subhasree and Koel Mullick etc have also been adorned with jewellery from GAJA.
The company will continue to invest in brand building and the company has launched collection specific brands. These collections are targetted at specific consumer groups and cater to different price points and interests.
The brands have an organic growth strategy and will expand through franchisee and distributorship network.
The company regularly participates in Trade Fairs and Exhibitions to promote and market its brands and products.

 Company came out with an IPO in 2010 @ Rs.260 and its current book value is over Rs.118.Stock is currently trading around Rs.30 .Recommending a STRONG BUY at current market price of  for long term investors.Stock traded in NSE under symbol 'SGJHL' and in BSE with scrip code 533180.

Disc : It is safe to assume that I  have vested interest in "

Shree Ganesh Jewellery House (I) Ltd

".